Clinical Trial

Assessing the Utility of Plasma ctHPVDNA for Anal Cancer Screening

Study acronym: SCAN-LITE
Completed
View on ClinicalTrials.gov →
Summary
The study is to test a liquid biopsy assay for screening and classifying anal dysplasia from blood.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-05-12; most recent amendment 2026-04-27.
Status change: Active, Not Recruiting → Completed 2026-04-27
Status change: Recruiting → Active, Not Recruiting 2025-11-26
Trial Details
NCT Number NCT06971276
Lead Sponsor Massachusetts Eye and Ear Infirmary
Conditions Anal Dysplasia
Enrollment 104 participants
Start Date 2024-04-03
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-28